Peptic Ulcer and Gastrointestinal Hemorrhage Associated With Nonsteroidal Anti-inflammatory Drug Use in Patients Younger Than 65 Years: A Large Health Maintenance Organization Cohort Study

Archives of Internal Medicine

Volumn 155, Issue 13, 1995, Pages 1371-1377

  Lanza, Lee L ^a   Walker, Alexander M ^a,c   Bortnichak, Edward A ^b,d   Dreyer, Nancy A ^a  

^a Epidemiology Resources Inc   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC;

ADULT; ARTICLE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PEPTIC ULCER; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEALTH MAINTENANCE ORGANIZATIONS; HUMAN; INCIDENCE; MALE; MIDDLE AGE; PEPTIC ULCER; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0029055187     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1995.00430130043005     Document Type: Article

References (27)

1. Bollini P, Garcia Rodríguez LA, Pérez Gutthann S, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of NSAIDs on upper gastrointestinal pathology. Arch Intern Med. 1992;152:1289-1295.
2. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991;115:787-796.
3. Garcia Rodríguez LA, Walker AM, Pérez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology. 1992;3:337-342.
4. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med. 1991; 91:213-222.
5. Griffin MR, Ray WA, Schaffner W. Non-steroidal anti-inflammatory drugs and death from peptic ulcer in elderly persons. Ann Intern Med. 1988;109:359-363.
6. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114:257-263.
7. Henry D, Dobson A, Turner C, Hall P, Forbes C, Patey P. NSAIDs and risk of upper gastrointestinal bleeding. Lancet. 1991;337:730.
8. Holvoet J, Terriere L, Van Hee W, Verbist L, Fierens E, Hautekeete ML. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study. Gut. 1991;32:730-734.
9. Laporte J, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet. 1991;337:85-89.
10. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal anti-inflammatory drug therapy. Arthritis Rheum. 1993;36:84-90.
11. International Classification of Diseases: Clinical Modification, Ninth Revision. Salt Lake City, Utah: Med-Index Publications; 1992.
12. Department of Coding and Nomenclature, American Medical Association. Physicians' Current Procedural Terminology. 4th ed. Chicago, Ill: American Medical Association; 1990.
13. HCFA Common Procedure Coding System. Minneapolis: State of Minnesota, Dept of Human Services, Blue Cross/Blue Shield of Minnesota, Physicians Health Plan; 1989.
14. Strom BL, Carson, JL. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev. 1990;12:87-107.
15. Walker AM. Observation and Inference. Newton Lower Falls, Mass: Epidemiology Resources Inc; 1991.
16. Physicians' Desk Reference. 45th ed. Oradell, NJ: Medical Economics Data; 1991.
17. EGRET. Seattle, Wash: Statistics and Epidemiology Research Corp; 1990.
18. SAS System for Personal Computers, Release 6.04. Cary, NC: SAS Institute Inc; 1988.
19. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:769-772.
20. Kurata JH, Nogawa AN, Abbey DE, Petersen F. A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists. Gastroenterology. 1992;102: 902-909.
21. Bonnevie O. The incidence of gastric ulcer in Copenhagen County. Scand J Gastroenterol. 1975;10:231-239.
22. Bonnevie O. The incidence of duodenal ulcer in Copenhagen County. Scand J Gastroenterol. 1975;10:385-393.
23. Kurata JH, Honda GB, Frankl H. The incidence of duodenal and gastric ulcers in a large health maintenance organization. Am J Public Health. 1985;75:625-629.
24. Graves EJ. National Hospital Discharge Survey: annual summary, 1990. Vital Health Stat 13. 1992; No. 112.
25. Kurata JH, Haile BM. Epidemiology of peptic ulcer disease. Clin Gastroenterol. 1989;96:569-580.
26. Kurata JH, Elashoff JD, Nogawa AN, Haile BM. Sex and smoking differences in duodenal ulcer mortality. Am J Public Health. 1986;76:700-702.
27. Van Staa TP, Abenhaim L, Leufkens H. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies. J Clin Epidemiol. 1994;47:183-189.